- Trials with a EudraCT protocol (180)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (39)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: ACYCLOVIR MULTIPLE-DOSE PHARMACOKINETIC ANALYSES IN PEDIATRIC PATIENTS WITH HERPESVIRUS INFECTIONS |
| Active substance: ACICLOVIR |
| Study summary document link (including results): Study P12-22 Aciclovir.xls |
| View full study record |
| Document reference: 46216 |
| Study title: Cavallieri S.. Int Congress of Italian Soc. for study of Infect. & Parasit. Dis.1979. Clinical application of Isoprinosine in the treatment of varicella and herpes zoster infectionsCavallieri S.. Int Congress of Italian Soc. for study of Infect. & Parasit. Dis.1979. Clinical application of Isoprinosine in the treatment of varicella and herpes zoster infections |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30085 |
| Study title: Deruiter A, Thin RN. Genital herpes - a guide to pharmacological therapy. Drugs 1994; 47(2):297-304.Deruiter A, Thin RN. Genital herpes - a guide to pharmacological therapy. Drugs 1994; 47(2):297-304. |
| Active substance: Foscarnet |
| Study summary document link (including results): Deruiter A et al 1994.pdf |
| View full study record |
| Document reference: 39632 |
| Study title: Enright AM, Prober C. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections. [Review] [99 refs]. Herpes 2003; 10(2):32-37.Enright AM, Prober C. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections. [Review] [99 refs]. Herpes 2003; 10(2):32-37. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Enright AM et al 2003.pdf |
| View full study record |
| Document reference: 28594 |
| Study title: Frangoul H, Wills M, Crossno C, Engel M, Domm J. Acyclovir-resistant herpes simplex virus pneumonia post-unrelated stem cell transplantation: a word of caution. Pediatr Transplant. 2007 Dec;11(8):942-4.Frangoul H, Wills M, Crossno C, Engel M, Domm J. Acyclovir-resistant herpes simplex virus pneumonia post-unrelated stem cell transplantation: a word of caution. Pediatr Transplant. 2007 Dec;11(8):942-4. |
| Active substance: Foscarnet |
| Study summary document link (including results): Frangoul H et al 2007.pdf |
| View full study record |
| Document reference: 39617 |
| Study title: Gershon AA. Prevention and treatment of VZV infections in patients with HIV. Herpes. 2001; 8(2):32-36.Gershon AA. Prevention and treatment of VZV infections in patients with HIV. Herpes. 2001; 8(2):32-36. |
| Active substance: Foscarnet |
| Study summary document link (including results): Gershon AA 2001.pdf |
| View full study record |
| Document reference: 39645 |
| Study title: Griffiths PD. Progress in the clinical management of herpes virus infections. Antiviral-Chemistry- Chemotherapy 1995; 6(4):191-209.Griffiths PD. Progress in the clinical management of herpes virus infections. Antiviral-Chemistry- Chemotherapy 1995; 6(4):191-209. |
| Active substance: Foscarnet |
| Study summary document link (including results): Griffiths PD 1995.pdf |
| View full study record |
| Document reference: 39671 |
| Study title: Grose C. Childhood infections with human herpesviruses types 6, 7, and 8. Advances in Pediatric Infectious Diseases 1996; 12:181-208.Grose C. Childhood infections with human herpesviruses types 6, 7, and 8. Advances in Pediatric Infectious Diseases 1996; 12:181-208. |
| Active substance: Foscarnet |
| Study summary document link (including results): Grose C. 1996.pdf |
| View full study record |
| Document reference: 39666 |
| Study title: Gross G, Braun D. 2006. [Efficacy and tolerability of topical foscarnet sodium in treatment of herpes labialis. Results of postmarketing surveillance]. Hautarzt 2006; 57(1):40-46.Gross G, Braun D. 2006. [Efficacy and tolerability of topical foscarnet sodium in treatment of herpes labialis. Results of postmarketing surveillance]. Hautarzt 2006; 57(1):40-46. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Gross G, Braun D 2006.pdf |
| View full study record |
| Document reference: 39590 |
| Study title: Mindel A. Recent advances in genital herpes. Annals of the Academy of Medicine, Singapore 1995; 24(4):584-592.Mindel A. Recent advances in genital herpes. Annals of the Academy of Medicine, Singapore 1995; 24(4):584-592. |
| Active substance: Foscarnet |
| Study summary document link (including results): Mindel A 1995.pdf |
| View full study record |
| Document reference: 39673 |
| Study title: Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. |
| Active substance: Foscarnet |
| Study summary document link (including results): Mocroft A et al 1996.pdf |
| View full study record |
| Document reference: 39669 |
| Study title: Naik HR, Siddique N, Chandrasekar PH. Foscarnet therapy for acyclovir resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients. Clinical Infectious Diseases 1995; 21(6):1514-1515. Naik HR, Siddique N, Chandrasekar PH. Foscarnet therapy for acyclovir resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients. Clinical Infectious Diseases 1995; 21(6):1514-1515. |
| Active substance: Foscarnet |
| Study summary document link (including results): Naik HR et al 1995.pdf |
| View full study record |
| Document reference: 39674 |
| Study title: Ongrádi J, Kövesdi V, Medveczky GP. Human herpesvirus 6; Orv Hetil. 2010 Mar 28;151(13):523-32.Ongrádi J, Kövesdi V, Medveczky GP. Human herpesvirus 6; Orv Hetil. 2010 Mar 28;151(13):523-32. |
| Active substance: Foscarnet |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39604 |
| Study title: Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J et al. A controlled trial comparing foscarnet with vidarabine for acyclovir- resistant mucocutaneous herpes-simplex in the acquired- immunodeficiencysyndrome. New-England-Journalof- Medicine 325 (8): 551-555.Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J et al. A controlled trial comparing foscarnet with vidarabine for acyclovir- resistant mucocutaneous herpes-simplex in the acquired- immunodeficiencysyndrome. New-England-Journalof- Medicine 325 (8): 551-555. |
| Active substance: Foscarnet |
| Study summary document link (including results): Safrin S et al 1991.pdf |
| View full study record |
| Document reference: 39631 |
| Study title: Sarin P. GENITAL HERPES-SIMPLEX INFECTIONS IN PATIENTS WITH THE ACQUIRED- IMMUNODEFICIENCY-SYNDROME. Pharmacotherapy 1994; 14(5):529-542.Sarin P. GENITAL HERPES-SIMPLEX INFECTIONS IN PATIENTS WITH THE ACQUIRED- IMMUNODEFICIENCY-SYNDROME. Pharmacotherapy 1994; 14(5):529-542. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Sarin P. 1994.pdf |
| View full study record |
| Document reference: 28571 |
| Study title: Zerr DM, Gupta D, Huang ML, Carter R, Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clinical Infectious Diseases. 2002; 34(3):309-317.Zerr DM, Gupta D, Huang ML, Carter R, Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clinical Infectious Diseases. 2002; 34(3):309-317. |
| Active substance: Foscarnet |
| Study summary document link (including results): Zerr DM et al 2002.pdf |
| View full study record |
| Document reference: 39643 |
| Study title: Wittek M, Doerr HW, Allwinn R. Varicella and herpes zoster. Part 2: therapy and prevention Med Klin (Munich). 2010 Jun;105(6):399- 403.Wittek M, Doerr HW, Allwinn R. Varicella and herpes zoster. Part 2: therapy and prevention Med Klin (Munich). 2010 Jun;105(6):399- 403. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Wittek M et al 2010.pdf |
| View full study record |
| Document reference: 39602 |
| Study title: Beijing da Xue Xue Bao 2003; Yi(6):596-599.Eksborg S. The pharmacokinetics of antiviral therapy in paediatric patients. [Review] [42 refs]. Herpes 2003; 10(3):66-71.Beijing da Xue Xue Bao 2003; Yi(6):596-599.Eksborg S. The pharmacokinetics of antiviral therapy in paediatric patients. [Review] [42 refs]. Herpes 2003; 10(3):66-71. |
| Active substance: FOSCARNET |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28593 |
| Study title: Bendel A, Gross T, Woods W, Edelman C, Balfour H. 1993. Failure of foscarnet in disseminated herpes zoster. Lancet (North American Edition) 1993; 341(8856):1342.Bendel A, Gross T, Woods W, Edelman C, Balfour H. 1993. Failure of foscarnet in disseminated herpes zoster. Lancet (North American Edition) 1993; 341(8856):1342. |
| Active substance: Foscarnet |
| Study summary document link (including results): Bendel A et al 1993.pdf |
| View full study record |
| Document reference: 39619 |
| Study title: Bernstein DI, Schleupner CJ, Evans TG, Blumberg DA, Bryson Y, Grafford K et al. Effect of foscarnet cream on experimental UV radiation-induced herpes labialis. Antimicrobial Agents & Chemotherapy 1997; 41(9):1961-1964.Bernstein DI, Schleupner CJ, Evans TG, Blumberg DA, Bryson Y, Grafford K et al. Effect of foscarnet cream on experimental UV radiation-induced herpes labialis. Antimicrobial Agents & Chemotherapy 1997; 41(9):1961-1964. |
| Active substance: Foscarnet |
| Study summary document link (including results): Bernstein DI et al 1997.pdf |
| View full study record |
| Document reference: 39656 |
